https://www.selleckchem.com/pr....oducts/BMS-754807.ht
79, 95% CI 0.66-0.93) compared to 2016. Other factors associated with viraemia were male gender (aOR 1.68, 95% CI 1.53-1.86), geographical region, injecting in past year (aOR 1.26, 95% CI 1.13-1.41), imprisonment (aOR 1.14, 95% CI 1.04-1.31) and homelessness (aOR 1.17, 95% CI 1.04-1.31). Among non-viraemic PWID with known infection, the proportion reporting ever receiving treatment increased in 2017 (28.7%, p less then 0.001) and 2018 (38.9%, p less then 0.001) compared to 2016 (14.5%). In conclusion, there has been a small reduction
Like
Comment
Share
